DE69223939T2 - Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren - Google Patents

Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Info

Publication number
DE69223939T2
DE69223939T2 DE69223939T DE69223939T DE69223939T2 DE 69223939 T2 DE69223939 T2 DE 69223939T2 DE 69223939 T DE69223939 T DE 69223939T DE 69223939 T DE69223939 T DE 69223939T DE 69223939 T2 DE69223939 T2 DE 69223939T2
Authority
DE
Germany
Prior art keywords
cpv
protein
related viruses
vaccine against
fplv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69223939T
Other languages
English (en)
Other versions
DE69223939D1 (de
Inventor
Valdes Elena Cortes
Olmo Carmen Vela
Alvarez Jose Casal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inmunologia y Genetica Aplicada SA
Original Assignee
Inmunologia y Genetica Aplicada SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia y Genetica Aplicada SA filed Critical Inmunologia y Genetica Aplicada SA
Publication of DE69223939D1 publication Critical patent/DE69223939D1/de
Application granted granted Critical
Publication of DE69223939T2 publication Critical patent/DE69223939T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69223939T 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren Expired - Lifetime DE69223939T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9100844A ES2026826A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados.
PCT/ES1992/000031 WO1992017205A1 (es) 1991-03-26 1992-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados

Publications (2)

Publication Number Publication Date
DE69223939D1 DE69223939D1 (de) 1998-02-12
DE69223939T2 true DE69223939T2 (de) 1998-07-09

Family

ID=8271929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69223939T Expired - Lifetime DE69223939T2 (de) 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren

Country Status (8)

Country Link
US (1) US5882652A (de)
EP (1) EP0554414B1 (de)
AT (1) ATE161729T1 (de)
AU (1) AU1585092A (de)
DE (1) DE69223939T2 (de)
DK (1) DK0554414T3 (de)
ES (1) ES2026826A6 (de)
WO (1) WO1992017205A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001833A1 (en) * 1991-07-17 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Improved vaccine
ES2065254B1 (es) * 1993-01-23 1995-07-16 Inmunologia & Genetica Aplic Peptidos y vacunas sinteticas contra parvovirus canino y otros virus relacionados.
US5785974A (en) * 1993-01-23 1998-07-28 Immunologia Y Genetica Aplicada, S.A. Synthetic peptides and vaccines against parvovirus
US5885585A (en) * 1994-11-08 1999-03-23 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
US5814510A (en) * 1994-11-08 1998-09-29 Cornell Research Foundation, Inc. Attenuated canine parvovirus vaccine
DK0914440T3 (da) * 1996-04-19 2007-05-21 Merial Ltd Nukleinsyrevaccination mod parvovirusinfektioner
US7556805B2 (en) 1996-12-10 2009-07-07 Sloan-Kettering Inststute for Cancer Research and The Animal Medical Center Compositions for treatment of melanoma and method of using same
WO1998025574A2 (en) * 1996-12-10 1998-06-18 Sloan-Kettering Institute For Cancer Research Stimulation of an immune response to differentiation antigen stimulated by altered antigen
EP0863151A1 (de) * 1997-02-12 1998-09-09 Akzo Nobel N.V. Hundeparvovirus DNA Impfstoffe
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US8021666B2 (en) 1997-02-18 2011-09-20 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to CD20 using a xenogeneic CD20 antigen
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6491907B1 (en) * 1998-11-10 2002-12-10 The University Of North Carolina At Chapel Hill Recombinant parvovirus vectors and method of making
AU4565401A (en) * 2000-03-14 2001-09-24 Thomas Jefferson University Production of chimeric capsid vectors
CN101124328A (zh) * 2004-12-15 2008-02-13 北卡罗来纳查佩尔山大学 嵌合载体
WO2007084773A2 (en) * 2006-01-20 2007-07-26 University Of North Carolina At Chapel Hill Enhanced production of infectious parvovirus vectors in insect cells
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
CN101815528A (zh) * 2007-06-14 2010-08-25 俄克拉荷马州大学评议会 包含犬细小病毒遗传性变体的疫苗
EP2391713A1 (de) 2009-01-30 2011-12-07 The Board Of Regents For Oklahoma State University Immunogene zusammensetzungen, impfstoffe und diagnostika auf der grundlage von in nordamerikanischen hunden verbreiteten hundestaupeviren
EP2396343B1 (de) 2009-02-11 2017-05-17 The University of North Carolina At Chapel Hill Modifizierte virusvektoren sowie verfahren zu ihrer herstellung und verwendung
CA2777692A1 (en) 2009-10-14 2011-04-21 Sanjay Kapil Isolation of a virus related to canine parvovirus-2 from a raccoon
WO2011088081A1 (en) 2010-01-12 2011-07-21 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
JP6042825B2 (ja) 2011-02-10 2016-12-14 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 改変された形質導入プロファイルを有するウイルスベクターならびにその製造および使用の方法
EP3738974A1 (de) 2012-09-28 2020-11-18 The University of North Carolina at Chapel Hill Gegen oligodendrozyten gerichtete aav-vektoren
EP3517612A1 (de) 2013-03-15 2019-07-31 The University of North Carolina At Chapel Hill Synthetische adenoassoziierte virusinvertierte endwiederholungssequenzen
EP3838297A1 (de) 2013-03-15 2021-06-23 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für duale glycanbindende aav-vektoren
CN104388394B (zh) * 2014-10-22 2017-03-15 中国农业科学院特产研究所 水貂细小病毒弱毒疫苗株及其在制备水貂细小病毒弱毒疫苗中的用途
MX2017006652A (es) 2014-11-21 2017-08-21 Univ North Carolina Chapel Hill Vectores de virus adeno-asociado (aav) dirigidos al sistema nervioso central.
EP3245220B1 (de) 2015-01-14 2023-09-20 The University of North Carolina at Chapel Hill Verfahren und zusammensetzungen für gezielten gentransfer
EP3611186A1 (de) 2015-02-06 2020-02-19 The University of North Carolina at Chapel Hill Optimierte genexpressionskassetten des menschlichen gerinnungsfaktors viii und deren verwendung
SG10202107733QA (en) 2015-09-28 2021-09-29 Univ North Carolina Chapel Hill Methods and compositions for antibody-evading virus vectors
WO2017190031A1 (en) 2016-04-28 2017-11-02 Indiana University Research And Technology Corporation Methods and compositions for resolving components of a virus preparation
AU2018234695A1 (en) 2017-03-15 2019-09-12 The University Of North Carolina At Chapel Hill Polyploid adeno-associated virus vectors and methods of making and using the same
WO2019060538A1 (en) 2017-09-20 2019-03-28 The Trustees Of Indiana University METHODS FOR LIPOPROTEIN RESOLUTION BY MASS SPECTROMETRY
CN107827958B (zh) * 2017-11-11 2020-08-25 中牧实业股份有限公司 犬细小病毒合成肽疫苗及其制备方法和应用
WO2019140233A1 (en) 2018-01-12 2019-07-18 The Trustees Of Indiana University Electrostatic linear ion trap design for charge detection mass spectrometry
CN112533644A (zh) 2018-04-03 2021-03-19 斯特里迪比奥公司 靶向眼组织的病毒载体
WO2019195449A1 (en) 2018-04-03 2019-10-10 Stridebio, Inc. Antibody-evading virus vectors
MX2020010466A (es) 2018-04-03 2021-01-08 Vectores de virus que evitan anticuerpos.
WO2019236139A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Interface for transporting ions from an atmospheric pressure environment to a low pressure environment
EP3803951B1 (de) 2018-06-04 2024-06-05 The Trustees of Indiana University Ladungsdetektionsmassenspektrometrie mit echtzeitanalyse und signaloptimierung
AU2019281715B2 (en) 2018-06-04 2024-06-13 The Trustees Of Indiana University Apparatus and method for capturing ions in an electrostatic linear ion trap
WO2019236143A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Apparatus and method for calibrating or resetting a charge detector
WO2019236142A1 (en) 2018-06-04 2019-12-12 The Trustees Of Indiana University Ion trap array for high throughput charge detection mass spectrometry
JP7285023B2 (ja) 2018-11-20 2023-06-01 ザ・トラスティーズ・オブ・インディアナ・ユニバーシティー 単一粒子質量分光分析のためのオービトラップ
EP3891777A1 (de) 2018-12-03 2021-10-13 The Trustees of Indiana University Vorrichtung und verfahren zur gleichzeitigen analyse mehrerer ionen mit einer elektrostatischen linearen ionenfalle
MX2021011468A (es) 2019-03-21 2021-12-15 Vectores de virus adenoasociados recombinantes.
WO2020219527A1 (en) 2019-04-23 2020-10-29 The Trustees Of Indiana University Identification of sample subspecies based on particle charge behavior under structural change-inducing sample conditions
CN113767110A (zh) 2019-04-26 2021-12-07 北卡罗来纳-查佩尔山大学 用于双重聚糖结合aav2.5载体的方法和组合物
WO2021076925A1 (en) 2019-10-17 2021-04-22 Stridebio, Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
JP2023547992A (ja) 2020-10-28 2023-11-15 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 二重グリカン結合ａａｖ２．５ベクターのための方法および組成物
WO2022093769A1 (en) 2020-10-28 2022-05-05 The University Of North Carolina At Chapel Hill Methods and compositions for dual glycan binding aav2.5 vector
CN112553168B (zh) * 2020-12-23 2022-03-08 江苏省农业科学院 分泌抗猫细小病毒vp2蛋白单克隆抗体的杂交瘤细胞3a6株及其应用
TW202242124A (zh) 2021-01-14 2022-11-01 美商史崔德生物公司 靶向ｔ細胞之ａａｖ載體
WO2022221529A1 (en) 2021-04-16 2022-10-20 Asklepios Biopharmaceutical, Inc. Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
WO2023150687A1 (en) 2022-02-04 2023-08-10 Ginkgo Bioworks, Inc. Recombinant adeno-associated virus vectors, and methods of use thereof
WO2024124019A2 (en) 2022-12-07 2024-06-13 Ginkgo Bioworks, Inc. Aav vectors targeting hematopoietic stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193990A (en) * 1979-02-16 1980-03-18 Cornell Research Foundation, Inc. Heterotypic canine parvovirus vaccine
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
WO1988002026A1 (en) * 1986-09-08 1988-03-24 Applied Biotechnology, Inc. Empty viral capsid vaccines
US4870023A (en) * 1987-03-16 1989-09-26 American Biogenetic Sciences, Inc. Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
JP2755817B2 (ja) * 1988-11-14 1998-05-25 アメリカ合衆国 パルボウイルスキャプシド
US5785974A (en) * 1993-01-23 1998-07-28 Immunologia Y Genetica Aplicada, S.A. Synthetic peptides and vaccines against parvovirus

Also Published As

Publication number Publication date
DE69223939D1 (de) 1998-02-12
DK0554414T3 (da) 1998-09-07
EP0554414A1 (de) 1993-08-11
ES2026826A6 (es) 1992-05-01
EP0554414B1 (de) 1998-01-07
WO1992017205A1 (es) 1992-10-15
AU1585092A (en) 1992-11-02
ATE161729T1 (de) 1998-01-15
US5882652A (en) 1999-03-16

Similar Documents

Publication Publication Date Title
DE69223939T2 (de) Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren
DE69222840T2 (de) Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus
KR920703831A (ko) 백신(vaccines)
JP6346143B2 (ja) 組換え弱毒化パルボウイルス
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
NO871313D0 (no) Fremgangsmaate for fremstilling av virusvaksine.
Xu et al. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection
RU2001101426A (ru) Аттенуированные вирусы с минус-цепью с измененной антагонистической в отношении интерферона активностью для применения в качестве вакцин и фармацевтических веществ
DE69536138D1 (de) Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
RU2012119494A (ru) Выделение вируса, родственного парвовирусу-2 собак, от енота
JP2021501757A (ja) 狂犬病ウイルスワクチン
Fahey et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
JP2009544303A5 (de)
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
Mebatsion Introduction to Veterinary Vaccines
Sheppard Viral vectors for veterinary vaccines
CA2366056A1 (en) Non-spreading pestivirus
ES2650622T3 (es) Vacunas que contienen variantes genéticas de parvovirus canino
Ghafari et al. Cloning and secretory expression of VP2 gene of infectious bursal disease virus in eukaryotic cells
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
Pastoret et al. Regulatory considerations for emergency use of vaccines in the European Union
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
JP2012139193A (ja) 融合タンパク質
Wang et al. Jun Luo", Hehe Shi*"*", Yeping Tan", Xuefeng Niu", Teng Long", Jing Zhao", Qin Tian"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 554414

Country of ref document: EP